Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: GlobalData
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sangamo Biosciences Inc reaffirms FY 2014 revenue guidance

Tuesday, 6 May 2014 04:02pm EDT 

Sangamo Biosciences Inc:Expects that revenues will be in the range of $45 to $50 million in FY 2014, inclusive of research funding and certain milestone payments from Shire and Biogen.FY 2014 revenue of $46 million - Thomson Reuters I/B/E/S. 

Company Quote

0.43 +3.03%
26 Dec 2014